Mark Sullivan

Conseiller Juridique Général chez DEFINIUM THERAPEUTICS, INC. Fortune : 17 M $ au 31/07/2026

Profil

Mark R.
Sullivan is currently a Member at the Association of Corporate Counsel and serves as Secretary & Chief Legal Officer at Definium Therapeutics, Inc. since 2023.
Formerly, Mr. Sullivan was Secretary & General Counsel at Sesen Bio, Inc. from 2019 to 2023; Secretary & Chief Compliance Officer at MedQuist, Inc. from 2003 to 2012; Secretary & Chief Compliance Officer at MModal LLC from 2006 to 2012; General Counsel at MModal MQ, Inc. from 2004 to 2006; Attorney at Drinker Biddle & Reath LLP from 1998 to 2000; Attorney at Pepper Hamilton LLP; and VP & Category Manager-Rehab Product at Invacare Corp.
Education includes undergraduate studies at the University of Pennsylvania and graduate studies at Rutgers Law School.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
DEFINIUM THERAPEUTICS, INC. 0,29 %	12/08/2026	383 071 ( 0,29 % )	17 M $	31/07/2026

Postes actifs de Mark Sullivan

Sociétés	Poste	Début
DEFINIUM THERAPEUTICS, INC.	Conseiller Juridique Général	13/04/2023
Association of Corporate Counsel	Corporate Officer/Principal	-

Anciens postes connus de Mark Sullivan

Sociétés	Poste	Fin
CARISMA THERAPEUTICS, INC.	Compliance Officer	07/03/2023
MModal LLC	Compliance Officer	01/07/2012
MedQuist, Inc.	Public Communications Contact	25/05/2012
MModal MQ, Inc.	Conseiller Juridique Général	01/09/2006
Drinker Biddle & Reath LLP	Conseiller Juridique Général	01/01/2000